DEMI SOULET: Open Payments
NPI 1558879767 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,019 in 161 payments from 20 companies in 2025. Trend: 2023 $2,454 · 2024 $4,419 · 2025 $6,019
Food & beverage: $4,052Consulting: $900Speaker / faculty: $600Travel & lodging: $459Education: $8
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 33 | $2,327 |
| Galderma Laboratories, L.P. | 13 | $885 |
| GENZYME CORPORATION | 15 | $534 |
| ABBVIE INC. | 24 | $348 |
| Regeneron Healthcare Solutions, Inc. | 8 | $347 |
| Novartis Pharmaceuticals Corporation | 13 | $258 |
| PFIZER INC. | 15 | $249 |
| UCB, Inc. | 10 | $241 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $190 |
| Amgen Inc. | 2 | $138 |
Products named: TREMFYA, DUPIXENT, NEMLUVIO, Bimzelx, CIBINQO, RINVOQ, SKYRIZI, OTEZLA.
Industry payments across FL — which companies pay providers there.
